spacer
spacer

PDBsum entry 3pba

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transcription PDB id
3pba

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
262 a.a.
249 a.a.
Ligands
ZXG
PGO
Waters ×165
PDB id:
3pba
Name: Transcription
Title: Crystal structure of ppargamma ligand binding domain in complex with monosulfate tetrabromo-bisphenol a (monotbbpa)
Structure: Peroxisome proliferator-activated receptor gamma. Chain: a, b. Fragment: ligand binding domain. Synonym: ppar-gamma, nuclear receptor subfamily 1 group c member 3. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: pparg, nr1c3. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.30Å     R-factor:   0.192     R-free:   0.255
Authors: A.Le Maire,W.Bourguet
Key ref: A.Riu et al. (2011). Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites. Toxicol Sci, 122, 372-382. PubMed id: 21622942
Date:
20-Oct-10     Release date:   08-Jun-11    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
P37231  (PPARG_HUMAN) -  Peroxisome proliferator-activated receptor gamma from Homo sapiens
Seq:
Struc:
505 a.a.
262 a.a.
Protein chain
P37231  (PPARG_HUMAN) -  Peroxisome proliferator-activated receptor gamma from Homo sapiens
Seq:
Struc:
505 a.a.
249 a.a.
Key:    Secondary structure  CATH domain

 

 
Toxicol Sci 122:372-382 (2011)
PubMed id: 21622942  
 
 
Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites.
A.Riu, A.le Maire, M.Grimaldi, M.Audebert, A.Hillenweck, W.Bourguet, P.Balaguer, D.Zalko.
 
  ABSTRACT  
 
The capability of the flame retardants tetrabromobisphenol A (TBBPA) and tetrachlorobisphenol A (TCBPA) to activate peroxysome proliferator-activated receptors (PPARs) α, β, and γ and estrogen receptors (ERs) α and β has been recently investigated, but the activity of their biotransformation products and of their lower molecular weight analogues formed in the environment remains unexplored. The aim of this study was to investigate the relationship between the degree of halogenation of BPA analogues and their affinity and activity towards human PPARγ and ERs and to characterize active metabolites of major marketed halogenated bisphenols. The biological activity of all compounds was studied using reporter cell lines expressing these nuclear receptors (NRs). We used NR-based affinity columns to rapidly evaluate the binding affinity of halogenated bisphenols for PPARγ and ERs and to trap active metabolites of TBBPA and TCBPA formed in HepG2 cells. The agonistic potential of BPA analogs highly depends on their halogenation degree: the bulkier halogenated BPA analogs, the greater their capability to activate PPARγ. In addition, PPARγ-based affinity column, HGELN-PPARγ reporter cell line and crystallographic analysis clearly demonstrate that the sulfation pathway, usually considered as a detoxification process, leads for TBBPA and TCBPA, to the formation of sulfate conjugates which possess a residual PPARγ-binding activity. Our results highlight the effectiveness NR-based affinity columns to trap and characterize biologically active compounds from complex matrices. Polyhalogenated bisphenols, but also some of their metabolites, are potential disrupters of PPARγ activity.
 

 

spacer

spacer